Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma

NCT00138229 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

NIH

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: filgrastim
BIOLOGICAL: therapeutic autologous lymphocytes
DRUG: cyclophosphamide
DRUG: fludarabine phosphate

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]